Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.
about
p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcriptionThe Nrf2-antioxidant response element signaling pathway and its activation by oxidative stressActivation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interactionThe inflammatory and normal transcriptome of mouse bladder detrusor and mucosaConcerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damageEmerging functional cross-talk between the Keap1-Nrf2 system and mitochondriaRegulation of Nrf2-Mediated Phase II Detoxification and Anti-oxidant GenesMicrosecond molecular dynamics simulations of intrinsically disordered proteins involved in the oxidative stress responseNovel -Propeller of the BTB-Kelch Protein Krp1 Provides a Binding Site for Lasp-1 That Is Necessary for Pseudopodial ExtensionKeap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondriaStress-activated cap'n'collar transcription factors in aging and human diseaseBasic principles and emerging concepts in the redox control of transcription factorsAntioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistanceInhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosisDysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancerNrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in HL-60 cells induced by arsenite treatment.Novel small molecules relieve prothymosin alpha-mediated inhibition of apoptosome formation by blocking its interaction with Apaf-1.Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2.Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway.Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspectiveOxidant-induced cell death and Nrf2-dependent antioxidative response are controlled by Fra-1/AP-1Non-electrophilic modulators of the canonical Keap1/Nrf2 pathwayMultiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2.Chemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease preventionTwo-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism.Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation.Function of prothymosin alpha in chromatin decondensation and expression of thymosin beta-4 linked to angiogenesis and synaptic plasticity.The NRF2 activation and antioxidative response are not impaired overall during hyperoxia-induced lung epithelial cell deathProthymosin α overexpression contributes to the development of pulmonary emphysema.Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody.Molecular mechanisms of Nrf2-mediated antioxidant responseDual roles of Nrf2 in cancer.The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.
P2860
Q24310885-B3E0D00D-5258-4828-9CF3-8A0848D90164Q24648021-CB6C19C4-7D1C-4CFD-B507-32DF30F61D0AQ24656061-76851280-527F-4F9B-95F4-19826D8BFA63Q25257408-15D90778-BE91-49CB-97A3-3E4BAD5C6999Q26995211-E9B7797E-11AB-43B5-85B6-AB1227078EF2Q26996150-74592B55-968C-4D33-AC1C-76E4E954736BQ27000878-8CD833D7-38CB-4D78-9327-668F7D487737Q27313374-FC192C79-BF63-40DD-801D-0519CF51CC4FQ27657284-BB94471F-8B4A-485C-A69C-80C38E85FFFCQ28382872-DD85B9BC-D18B-40F9-97E9-A2F4ADA9FCCCQ28384526-197E3884-2014-4131-8D15-8FD3A545287CQ28384783-D6078CCB-0772-40B1-AFB6-431E2303365EQ28391506-1DCEBC11-5E1B-41FE-B0A6-AAE4E0D77FBCQ28392399-DDC8B51A-8CAA-46AA-836F-9AE34EE1466EQ28395156-3E5526CB-D59E-48BB-AFF1-C29F69F309BBQ28469051-814AEF67-2015-401F-B424-C1FE161B4B91Q28583647-873BA286-B287-4336-8D9E-497A80141443Q33520215-206B7C31-6A7D-4AA8-B120-C13EA3638964Q33640702-83B212E3-ED9E-4479-9B10-99BB179E47B7Q33779437-B45EA61E-F63F-4390-B33C-65EF0AEFFB97Q33900511-DDB7D0CB-62AB-41D4-B9FB-E3A0EEE172B7Q34003929-52D338C1-55D7-4E02-8212-9E58584B690EQ34059286-49180039-4102-415C-9C00-BAAD196E816EQ34062498-BB0F8599-DA4F-4862-9419-C4D0EF8C069EQ34441957-9048A849-97F1-42F2-9626-3F020A7F13D8Q34993085-C8352036-96CB-4918-9BA2-A15DBCE2377CQ35942469-D25A4F24-2071-42D1-92A8-FFCB15E55CE1Q35943342-D377C07D-5342-48D0-8512-5C1ED6EA9F8AQ36277241-7AC1491B-D0C8-4A1A-A126-017AAB66DE85Q36512148-1C391977-A6A7-4739-A83A-2DFC77EEC853Q36539849-95BC4447-B8E9-4C8B-937C-068E39A6A543Q36642707-9F8646D6-4C7F-49F7-9604-4D929F88BE54Q36719259-9C17BBB3-4608-436B-B5CA-5EA24B965779Q36818209-824E6184-7010-4DC5-B4DC-C04E20A295B3Q36848739-01FD3EBD-CC71-4D63-AFB1-1F14A136BB77Q36906886-E5345464-635C-41D9-9E0B-41FA5329C4CFQ36942477-927F1E13-4B2B-4825-82F9-D4B7601AC9D0Q37073173-1DCF8E89-5628-4D7E-A88B-4CE7F9B2931FQ37119963-45E68665-A0F3-4EA4-B209-D7994E4A5209Q37248671-0A2B262F-F90C-4962-9D2C-16176E06CE21
P2860
Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Nuclear oncoprotein prothymosi ...... ative stress-protecting genes.
@en
type
label
Nuclear oncoprotein prothymosi ...... ative stress-protecting genes.
@en
prefLabel
Nuclear oncoprotein prothymosi ...... ative stress-protecting genes.
@en
P2093
P2860
P50
P1476
Nuclear oncoprotein prothymosi ...... dative stress-protecting genes
@en
P2093
Andrey B Vartapetian
Elena A Sukhacheva
Grigoriy S Filonov
Irina S Abaeva
Nina V Chichkova
Ruben N Karapetian
Ulrich Schneider
Yuri P Rubtsov
P2860
P304
P356
10.1128/MCB.25.3.1089-1099.2005
P407
P577
2005-02-01T00:00:00Z